Organon (OGN) Net Margin (2020 - 2026)
Organon (OGN) recorded quarterly Net Margin of 10.0% in Q1 2026, up 173.51% quarter-over-quarter from 13.6% in Q4 2025, and up 425.0% on a YoY basis from 1.9% in Q1 2025.
Organon (OGN) Net Margin (2020 - 2026) Analysis & Trends
Organon's Net Margin history runs 6 years deep, the most recent figure standing at 10.0% for Q1 2026.
- In Q1 2026, Net Margin rose 425.0% year-over-year to 10.0%; the TTM figure through Mar 2026 stood at 3.99% (down 792.0% YoY), while the FY2025 annual figure was 3.01%, down 1049.0% from the prior year.
- Net Margin was 10.0% for Q1 2026 at Organon, up from 13.6% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 34.17% in Q4 2023 to a low of 13.6% in Q4 2025.
- Historically, Net Margin has averaged 10.76% across 4 years, with a median of 10.0% in 2026.
- Biggest YoY gain for Net Margin was 1887 bps in 2024; the steepest drop was 2732 bps in 2024.
- A 4-year view of Net Margin shows it stood at 34.17% in 2023, then sank by 80 bps to 6.85% in 2024, then sank by 299 bps to 13.6% in 2025, then soared by 174 bps to 10.0% in 2026.
- The last three Net Margin figures came in at 10.0% (Q1 2026), 13.6% (Q4 2025), and 9.99% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,134,969.93 Bn | 92,134,964.97 Bn | 7.76 Bn | 22.77% |
| 2 | Eli Lilly | 1,027.45 Bn | 1,022.17 Bn | 16.22 Bn | 37.36% |
| 3 | Johnson & Johnson | 559.08 Bn | 537.03 Bn | 15.96 Bn | 21.76% |
| 4 | AbbVie | 394.75 Bn | 385.40 Bn | 10.78 Bn | 4.65% |
| 5 | Merck | 295.12 Bn | 289.47 Bn | 12.09 Bn | -25.84% |
| 6 | Amgen | 186.65 Bn | 174.61 Bn | 5.87 Bn | 21.11% |
| 7 | Gilead Sciences | 159.22 Bn | 151.50 Bn | 5.52 Bn | 29.04% |
| 8 | Pfizer | 146.00 Bn | 133.23 Bn | -1.21 Bn | -0.56% |
| 9 | Bristol Myers Squibb | 113.22 Bn | 102.77 Bn | 8.07 Bn | 23.32% |
| 10 | Organon | 3.49 Bn | 2.37 Bn | 783.00 Mn | 10.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.00% |
| Dec 31, 2025 | -13.60% |
| Sep 30, 2025 | 9.99% |
| Jun 30, 2025 | 9.10% |
| Mar 31, 2025 | 5.75% |
| Dec 31, 2024 | 6.85% |
| Sep 30, 2024 | 22.69% |
| Jun 30, 2024 | 12.13% |
| Mar 31, 2024 | 12.39% |
| Dec 31, 2023 | 34.17% |
| Sep 30, 2023 | 3.82% |
| Jun 30, 2023 | 15.05% |
| Mar 31, 2023 | 11.51% |
| Jun 30, 2021 | -0.25% |
| Mar 31, 2021 | 0.27% |
| Dec 31, 2020 | -0.50% |
| Sep 30, 2020 | -0.81% |
| Jun 30, 2020 | -2.88% |
| Mar 31, 2020 | -1.74% |